64
Views
7
CrossRef citations to date
0
Altmetric
Original Research

What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study

, , , , , , , , , & show all
Pages 1881-1894 | Published online: 16 Aug 2016

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]Global Strategy for the Diagnosis, Management and Prevention of COPD2015 Available from: http://www.goldcopd.org/Accessed October 14, 2015
  • NardiniSAnnesi-MaesanoIDel DonnoMThe AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD modelMultidiscip Respir Med2014914625473523
  • QuanjerPHCorrectly defining criteria for diagnosing chronic obstructive pulmonary disease mattersAm J Respir Crit Care Med2014189223024428654
  • RennardSVestboJAgustiAReply: correctly defining criteria for diagnosing chronic obstructive pulmonary disease mattersAm J Respir Crit Care Med2014189223023124428653
  • QuanjerPHEnrightPLMillerMRThe need to change the method for defining mild airway obstructionEur Respir J201137372072221357929
  • Lung function testing: selection of reference values and interpretative strategies. American Thoracic SocietyAm Rev Respir Dis19911445120212181952453
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
  • Mohamed HoeseinFAZanenPLammersJWLower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based reviewRespir Med2011105690791521295958
  • DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
  • RabeKFWedzichaJAWoutersEFEuropean Respiratory Monograph 59: COPD and Comorbidity59LausanneEuropean Respiratory Society2013
  • FabbriLMRabeKFFrom COPD to chronic systemic inflammatory syndrome?Lancet2007370958979779917765529
  • DahlMVestboJLangePBojesenSETybjaerg-HansenANordestgaardBGC-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175325025517053205
  • MehrotraNFreireAXBauerDCHealth ABC StudyPredictors of mortality in elderly subjects with obstructive airway disease: the PILE scoreAnn Epidemiol201020322323220159492
  • CelliBRLocantoreNYatesJECLIPSE InvestigatorsInflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185101065107222427534
  • HolleRHappichMLöwelHWichmannHEMONICA/KORA Study GroupKORA – a research platform for population based health researchGesundheitswesen200567suppl 1S19S2516032513
  • KarraschSFlexederCBehrJKORA Study GroupSpirometric reference values for advanced age from a south German populationRespiration201385321021922797415
  • PetersADöringALadwigKHMultimorbidity and successful aging: the population-based KORA-Age studyZ Gerontol Geriatr20114424154 German22270973
  • LöwelHDöringASchneiderAMONICA/KORA Study GroupThe MONICA Augsburg surveys – basis for prospective cohort studiesGesundheitswesen200567suppl 1S13S1816032512
  • QuanjerPHHallGLStanojevicSColeTJStocksJGlobal LungsIAge- and height-based prediction bias in spirometry reference equationsEur Respir J201240119019722183491
  • KirchbergerIMeisingerCHeierMPatterns of multimorbidity in the aged population. Results from the KORA-age studyPLoS One201271e3055622291986
  • SpitzerRJKroenkeKWilliamsJBWLöweBA brief measure for assessing generalized anxiety disorderArch Intern Med2006166101092109716717171
  • YesavageJASheikhJIGeriatric depression scale (GDS). Recent evidence and development of a shorter versionClin Gerontol198651–2165173
  • van DijkWTanWLiPCanCOLD Study GroupClinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohortAnn Fam Med2015131414825583891
  • TurkeshiEVaesBAndreevaEAirflow limitation by the Global lungs initiative equations in a cohort of very old adultsEur Respir J201546112313225882799
  • MolariusASeidellJCKuulasmaaKDobsonAJSansSSmoking and relative body weight: an international perspective from the WHO MONICA ProjectJ Epidemiol Community Health19975132522609229053
  • IslamMMValderasJMYenLDawdaPJowseyTMcRaeISMultimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patternsPLoS One201491e8378324421905
  • SmithMWrobelJEpidemiology and clinical impact of major comorbidities in patients with COPDInt J Chron Obstruct Pulmon Dis2014987188825210449
  • TzanakisNHillasGPerlikosFTsiligianniIManaging comorbidities in COPDInt J Chron Obstruct Pulmon Dis2015109510925609943
  • DivoMJCasanovaCMarinJMBODE Collaborative GroupCOPD comorbidities networkEur Respir J201546364065026160874
  • BaldiSBruschiCMaestriRThe mediating role of cytokine IL-6 on the relationship of FEV1 upon 6-minute walk distance in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201491091109925336940
  • SilvaDRGazzanaMBKnorstMMC-reactive protein levels in stable COPD patients: a case-control studyInt J Chron Obstruct Pulmon Dis2015101719172526357470
  • CrieeCPSorichterSSmithHJWorking Group for Body Plethysmography of the German Society for Pneumology and Respiratory CareBody plethysmography – its principles and clinical useRespir Med2011105795997121356587